These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6843740)

  • 1. Effect of naloxone on shock in a patient with fulminant hepatic failure.
    De Groot GH; Schalm SW; Dirksen R; Valk KC; Boks AL
    Neth J Med; 1983; 26(3):77-9. PubMed ID: 6843740
    [No Abstract]   [Full Text] [Related]  

  • 2. Naloxone for haemorrhagic fever shock?
    Xing R; Yi X; Guang-Min L; Yuan-Wen W
    Trop Doct; 1990 Apr; 20(2):72-3. PubMed ID: 1973008
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of naloxone in first aid].
    Accettelli U; Ambrosi F; Russo L; De Petris U; Stagnitti F
    Clin Ter; 1982 Jul; 102(2):197-201. PubMed ID: 7140177
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic effect of naloxone and its mechanisms in circulation shock].
    He F; Zheng MQ
    Sheng Li Ke Xue Jin Zhan; 1989 Apr; 20(2):137-43. PubMed ID: 2555915
    [No Abstract]   [Full Text] [Related]  

  • 5. [Naloxone and endogenous opiates in shock].
    Nielsen JV; Lundgren LG
    Lakartidningen; 1984 Oct; 81(41):3717-8. PubMed ID: 6094928
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biological study of the human liver in shock].
    Grimaud D; Philip F; Livrelli N; Sudaka P; Maestracci P
    Ann Anesthesiol Fr; 1979; 20(2):79-88. PubMed ID: 38712
    [No Abstract]   [Full Text] [Related]  

  • 7. [Shock and the administration of naloxone].
    Jolivet M; Laurion M
    Union Med Can; 1984 Sep; 113(9):783-5. PubMed ID: 6506352
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of naloxone in refractory shock].
    Cattani F; Grillanda G
    Recenti Prog Med; 1982 May; 72(5):647-52. PubMed ID: 6753065
    [No Abstract]   [Full Text] [Related]  

  • 9. [The experimental use of naloxone in the management of shock].
    Bass A; Hirshberg A; Schneiderman J
    Harefuah; 1985 Apr; 108(8):407-9. PubMed ID: 4043860
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic mucormycosis in a child with fulminant hepatic failure.
    Erdem G; Cağlar M; Ceyhan M; Akçören Z; Kanra G
    Turk J Pediatr; 1996; 38(4):511-4. PubMed ID: 8993182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early fulminant graft failure in orthotopic liver transplantation with massive haemorrhagic necrosis.
    Zimmermann A; Lerut J
    Ital J Gastroenterol; 1995 Dec; 27(9):501-5. PubMed ID: 8919320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The endocrine system and shock].
    Scriba PC; Djonlagic H; Müller-Esch G
    Internist (Berl); 1982 Aug; 23(8):433-40. PubMed ID: 6127327
    [No Abstract]   [Full Text] [Related]  

  • 13. [New perspectives in the treatment of shock. Use of naloxone].
    González-Esparza L
    Rev Med Univ Navarra; 1982 Mar; 26(1):55-8. PubMed ID: 7111954
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of nalorphine and naloxone on the course of electric pain shock in rabbits].
    Golanov EV; Parin SB; Iasnetsov VV
    Biull Eksp Biol Med; 1982 Jun; 93(6):60-2. PubMed ID: 7115937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spontaneous hepatic rupture].
    González Bethencourt JV; Cáceres F; Thwayeb Y
    Rev Esp Enferm Apar Dig; 1981 Jun; 59(6):721-30. PubMed ID: 7291679
    [No Abstract]   [Full Text] [Related]  

  • 16. [Naloxone in the treatment and prevention of shock].
    Zou CM
    Zhonghua Nei Ke Za Zhi; 1988 Sep; 27(9):580-2. PubMed ID: 3068004
    [No Abstract]   [Full Text] [Related]  

  • 17. Naloxone in advanced cardiac life support: myth or reality?
    Mendoza-Davila N; Varon J
    Am J Emerg Med; 2008 Oct; 26(8):902-3. PubMed ID: 18926349
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Fulminant hepatic failure: histological quantitation of surviving liver parenchyma in the evaluation of the cause of death.
    Portmann B; Gazzard BG; Murray-Lyon IM; Williams R
    Gut; 1974 Oct; 15(10):830. PubMed ID: 4548019
    [No Abstract]   [Full Text] [Related]  

  • 19. Fulminant hepatic failure caused by ecarazine hydrochloride (a hydralazine derivative).
    Tameda Y; Hamada M; Takase K; Nakano T; Kosaka Y
    Hepatology; 1996 Mar; 23(3):465-70. PubMed ID: 8617425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone in shock.
    Lenz K; Druml W; Gassner A; Hruby K; Kleinberger G; Laggner A
    Lancet; 1981 Apr; 1(8224):834. PubMed ID: 6111691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.